ArticleUnited European gastroenterology journal2026
Eosinophilic Esophagitis and Autoimmune Thyroid Disease: A Population-Based Matched Cohort Study.
Article in United European gastroenterology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundEosinophilic esophagitis (EoE) is an immune-mediated disease typically presenting with esophageal symptoms. Although prior exploratory studies on the autoimmune comorbidity of EoE have indicated a possible association with autoimmune thyroid disease (AITD), this relationship has not been examined in detail.
methodsUsing the nationwide ESPRESSO cohort consisting of data from all 28 pathology departments in Sweden, we identified patients with biopsy-confirmed EoE diagnosed between 2006-2023. Each EoE patient was compared with general-population references matched on sex, age, county of residence, and calendar year of diagnosis. A secondary reference group consisted of full siblings of EoE patients. Cox proportional hazard model was used to estimate the hazard ratio (HR) of future AITD, whereas a logistic regression model was used to estimate the odds ratio (OR) of prior AITD.
resultsDuring follow-up, 70/5801 EoE patients developed AITD (incidence rate, 2.14/1000 person-years) compared to 271/27,407 references (1.74/1000 person-years), corresponding to an HR of 1.18 (95% CI, 0.91-1.54). Compared to sibling comparators, the HR was 1.27 (0.84-1.94). The prevalence of prior AITD was 3.9% in EoE, compared with 3.0% in references, corresponding to an OR of 1.29 (1.10-1.49). Notably, in childhood-onset EoE, the HR of future AITD was 2.53 (1.18-5.45) and the OR of prior AITD was 4.71 (2.34-9.43).
conclusionsEoE was associated with prior AITD, but not with future AITD. Childhood-onset EoE was however associated with both prior and future AITD. Physicians diagnosing EoE should be observant of symptoms indicative of AITD, especially in childhood-onset EoE.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.